1.05

5.41% -0.06

Skye Bioscience Inc (SKYE)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

$1.11

Offen:

$1.14

24-Stunden-Volumen:

346.00K

Relative Volume:

0.41

Marktkapitalisierung:

$33.66M

Einnahmen:

Nettoeinkommen (Verlust:

$-42.37M

KGV:

-0.9826

EPS:

-1.0686

Netto-Cashflow:

$-34.94M

1W Leistung:

+40.06%

1M Leistung:

-13.22%

6M Leistung:

-75.86%

1J Leistung:

-66.13%

1-Tages-Spanne:

$1.03

$1.14

1-Wochen-Bereich:

$0.731

$1.15

52-Wochen-Spanne:

$0.6844

$5.75

Skye Bioscience Inc Stock (SKYE) Company Profile

Firmenname

Skye Bioscience Inc

Sektor

Healthcare (1113)

Branche

Biotechnology (621)

Telefon

(858) 410-0266

Adresse

11250 EL CAMINO REAL, SUITE 100, SAN DIEGO

Mitarbeiter

Twitter

Nächster Verdiensttermin

2024-11-07

Neueste SEC-Einreichungen

SKYE's Discussions on Twitter

Vergleichen Sie SKYE mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
SKYE Skye Bioscience Inc.	3.10	12.89M	0	0	0	0.00
MOBBW Mobilicom Limited Warrants	3.64	4.50B	0	0	0	0.00
PSNYW Polestar Automotive Holding Uk	4.50	447.72M	2.07B	-1.42B	-1.37B	-0.6765
GOODO Gladstone Commercial Corporation	20.61	372.90M	0	0	0	0.00
SHMD Schmid Group N V	8.30	322.97M	0	0	0	0.00
DWLD Davis Select Worldwide ETF	47.49	0	0	0	0	0.00

Skye Bioscience Inc Stock (SKYE) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-10-06	Herabstufung	Cantor Fitzgerald	Overweight → Neutral
2025-10-06	Herabstufung	Craig Hallum	Buy → Hold
2025-08-15	Eingeleitet	Evercore ISI	Outperform
2025-02-28	Eingeleitet	William Blair	Outperform
2024-09-30	Eingeleitet	Scotiabank	Sector Outperform
2024-09-10	Eingeleitet	JMP Securities	Mkt Outperform
2024-07-09	Eingeleitet	Craig Hallum	Buy
2024-05-23	Eingeleitet	Cantor Fitzgerald	Overweight
2024-04-12	Eingeleitet	Oppenheimer	Outperform

Alle ansehen

Skye Bioscience Inc Aktie (SKYE) Neueste Nachrichten

Jan 08, 2026

Is Skye Bioscience Inc. (09R) stock a safe buy pre earnings2025 Winners & Losers & AI Powered Trade Plan Recommendations - ulpravda.ru

Jan 08, 2026

Is Skye Bioscience Inc. stock a safe haven asset2025 Price Momentum & Daily Volume Surge Trade Alerts - ulpravda.ru

Jan 08, 2026

Skye Bioscience, Inc. Securities Fraud Class Action Lawsuit Pend - GuruFocus

Jan 08, 2026

Is Skye Bioscience Inc. (09R) stock worth holding before Fed meetingPortfolio Gains Summary & Daily Stock Trend Watchlist - ulpravda.ru

Jan 08, 2026

Skye Bioscience, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before January 16, 2026 to Discuss Your RightsSKYE - PR Newswire

Jan 08, 2026

Jan 07, 2026

Lawsuit Alert: Investors who lost money with shares of Skye - openPR.com

Jan 07, 2026

A Look At Halozyme Therapeutics (HALO) Valuation After New ENHANZE Obesity Partnership With Skye Bioscience - Yahoo Finance

Jan 07, 2026

Jan 06, 2026

Burned by Skye Bioscience, Inc.? Contact Levi & Korsinsky to SueWallSt And Fight Back - ACCESS Newswire

Jan 06, 2026

SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Se - GuruFocus

Jan 06, 2026

SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit - Your Wyoming Link

Jan 06, 2026

Levi & Korsinsky Notifies Skye Bioscience, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – SKYE - GlobeNewswire

Jan 06, 2026

ROSEN, A TOP-RANKED LAW FIRM, Encourages Skye Bioscience, - GlobeNewswire

Jan 06, 2026

SKYE CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire

Jan 06, 2026

SKYE LAWSUIT ALERT: Levi & Korsinsky Notifies Skye Bioscience, Inc. InvestorsLead Plaintiff Deadline January 16, 2026 - ACCESS Newswire

Jan 06, 2026

Kuehn Law Encourages Investors of Skye Bioscience, Inc. to Contact Law Firm - PR Newswire

Jan 06, 2026

Lost Money on Skye Bioscience, Inc. (SKYE)? Contact Levi & Korsinsky Before January 16, 2026 to Join Class Action - ACCESS Newswire

Jan 06, 2026

HALO, Skye Bioscience team up on obesity drug development - Longevity.Technology

Jan 06, 2026

Skye Bioscience, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before January 16, 2026 to Discuss Your RightsSKYE - Finviz

Jan 06, 2026

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

Jan 06, 2026

INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience - Prime Publishers, Inc.

Jan 06, 2026

Portnoy Law Firm Announces Class Action on Behalf of Skye Bioscience, Inc. Investors - GlobeNewswire

Jan 06, 2026

Fibonacci Retracement Aligns with Support in Rudra Ecovation LimitedEx-Dividend Date Alerts & Free Long-Term Investment Planning - earlytimes.in

Jan 06, 2026

Investors in Skye Bioscience, Inc. (SKYE): Protect Your RightsContact Levi & Korsinsky Before January 16, 2026 - ACCESS Newswire

Jan 06, 2026

Jan 05, 2026

Shareholders of Skye Bioscience, Inc. (SKYE): Protect Your Rights Before January 16, 2026Contact Levi & Korsinsky - ACCESS Newswire

Jan 05, 2026

Shareholders SueWallSt in New Class Action Against Skye Bioscience, Inc.Act Now - Stockhouse

Jan 05, 2026

Citizens reiterates Market Outperform rating on Skye Bioscience stock By Investing.com - Investing.com Canada

Jan 05, 2026

Bronstein, Gewirtz & Grossman LLC Urges Skye Bioscience, - GlobeNewswire

Jan 05, 2026

SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire

Jan 05, 2026

The Gross Law Firm Notifies Shareholders of Skye Bioscience, Inc - GuruFocus

Jan 05, 2026

Skye Bioscience shares rise on Halozyme partnership to advance obesity treatment - MSN

Jan 05, 2026

Halozyme Therapeutics, Skye Bioscience Collaborate to Evaluate Nimacimab for Obesity Treatment - MarketScreener

Jan 05, 2026

Skye Bioscience Licenses Halozyme’s ENHANZE Drug Delivery Technology - Contract Pharma

Jan 05, 2026

The Gross Law Firm Notifies Shareholders of Skye Bioscience, Inc.(SKYE) of a Class Action Lawsuit and an Upcoming Deadline - Barchart.com

Jan 05, 2026

Skye Bioscience stock jumps after Halozyme collaboration for obesity drug By Investing.com - Investing.com Nigeria

Jan 05, 2026

Halozyme Therapeutics (HALO) Partners with Skye Bioscience for I - GuruFocus

Jan 05, 2026

Halozyme (HALO) Partners with Skye Bioscience for Obesity Treatm - GuruFocus

Jan 05, 2026

Skye Bioscience rises as it partners with Halozyme on obesity drug - TradingView — Track All Markets

Jan 05, 2026

Halozyme and Skye Bioscience Announce Global Collaboration and License Agreement to Evaluate Nimacimab Co-Formulated with ENHANZE® for Obesity - The Manila Times

Jan 05, 2026

SKYE ALERT: Securities Fraud Class Action Launched Against Skye Bioscience, Inc.January 16, 2026 Deadline - ACCESS Newswire

Jan 05, 2026

Jan 04, 2026

Class Action Lawsuit Alert: Levi & Korsinsky Reminds Skye Bioscience, Inc. (SKYE) Investors of January 16, 2026 Deadline - ACCESS Newswire

Jan 04, 2026

Levi & Korsinsky Urges Skye Bioscience, Inc. (SKYE) Shareholders to Act Before Lead Plaintiff Deadline January 16, 2026 - ACCESS Newswire

Jan 04, 2026

Class Action Lawsuit Filed: Skye Bioscience, Inc. (SKYE) – Join by January 16, 2026 – Contact Levi & Korsinsky - ACCESS Newswire

Jan 04, 2026

Jan 03, 2026

Will Breakout in Rathi Bars Limited Sustain Through Next WeekPortfolio Allocation Tips & Double Or Triple Returns - earlytimes.in

Jan 03, 2026

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience - Your Wyoming Link

Jan 03, 2026

Securities Fraud Class Action Filed Against Skye Bioscience, Inc. (SKYE)Levi & Korsinsky Reminds Investors of January 16, 2026 - ACCESS Newswire

Jan 03, 2026

Jan 02, 2026

Lost Money on Skye Bioscience, Inc.(SKYE)? Join Class Action Sui - GuruFocus

Jan 02, 2026

UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience - FinancialContent

Jan 02, 2026

Investor Alert: Deadline Approaching to Join Skye Bioscience, Inc. (SKYE) Class ActionContact Levi & Korsinsky - ACCESS Newswire

Jan 02, 2026